Piramal Pharma Solutions Invests CAD$25 Million to Expand its Facility in Aurora, Canada

Specifications:

Name:

Piramal Pharma Solutions Invests CAD$25 Million to Expand its Facility in Aurora, Canada

Location:

Aurora

Company:

Piramal Pharma Solutions

Estimated Cost:

CAD$25 Million

Source:

www.piramal.com

Introduction:

Piramal Enterprises Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), to expand its Aurora facility in Canada with the addition of a new state-of-the-art wing dedicated to manufacturing Active Pharmaceutical Ingredients (APIs).

Features:

Known for its world-class lab services and production plants, the Piramal Pharma Solutions' (PPS) Aurora facility will enhance its offerings to customers with this new addition that features ~10,500 sq. ft. of new manufacturing space.

The additional capacity will cater to increasing customer demand as well as support the facility's ability to provide APIs and HPAPIs down to an Occupational Exposure Limit (OEL) of 1mcg/m3. It will also include filtration and drying capabilities that will enhance service offerings at Piramal Pharma Solutions' Aurora facility.

This upcoming facility has been designed to meet the highest standards of global compliance and will employ highly qualified scientific, technical and professional staff, building on a business that has already seen staff numbers grow almost 2-fold to ~200 in recent years.